What happened in health care technology this week, and why it’s important.
New dissolvable heart monitors could help cardiologists battle AFib
Michael Walter starts the coverage this week with his article in Cardiovascular Business online. Researchers have developed new heart monitors that dissolve inside the body when no longer needed, sharing their work in Science Advances. The new-look devices are soft, flexible, transparent, and roughly the size of a postage stamp. The goal is to implant the device following a significant cardiac event or procedure so that it can restore normal heart rhythms, like a pacemaker, and stream data directly to the patient’s physicians. It can then be left to dissolve, helping patients avoid going through an additional procedure and saving healthcare providers the extraction costs.
Why it’s important – Several serious complications, including atrial fibrillation and heart block, can follow cardiac surgeries or catheter-based therapies. Many deaths that occur following heart surgery or a heart attack could be prevented if doctors had better tools to monitor and treat patients in the delicate weeks and months after these events take place.
Infographic of the week – From Halle Tecco – Large companies are playing an increasingly important role in the VC ecosystem. In fact, 26% of deals in Q1 of this year included corporate venture capital (CVC), an increase from 20% in 2022 and 11% in 2010. Here are 65 strategic healthcare investors, from health systems to biotech to health insurance companies, investing in startups and everything you should know about taking their money. Read her blog post here: http://www.halletecco.com/blog/strategic-cvc-healthcare-investors
Bridging the Digital Divide Through On-site, Health Center–Based Internet Clinics
Link Health, a Boston-based program that utilizes a three-pillar, community-based strategy, increased access to the Internet in marginalized communities by leveraging the Affordable Connectivity Program. Their program was featured in this article in NEJM Catalyst online. Link Health is a grassroots initiative designed to increase uptake of the ACP by establishing on-site, health center–based Internet clinics in historically underserved communities throughout the Greater Boston, Massachusetts area. By working with local community health centers and community-based organizations, Link Health functions as the intermediary between lower-income populations who qualify for the ACP and Internet service providers by raising awareness of the ACP and assisting individuals through the eligibility and sign-up process. In this article, the authors detail the strategies employed to maximize the uptake of the ACP in low-income communities.
Why it’s important – Increasing uptake of the ACP in vulnerable communities is possible by establishing on-site, health center–based Internet clinics in neighborhoods with high proportions of lower-income patients. Cultivating close partnerships with community-based organizations and healthcare sites is critical to reach the populations of interest effectively. Effective outreach and enrollment in target communities are possible by utilizing a get-out-the-vote framework and grassroots organizing strategy.
New Technologies, Ideas Push the Hospital at Home Concept Forward
Eric Wicklund in Health Leaders online interviews eight different health systems who said the future may lie in modifying the model to suit each organization’s specific care needs and resources, even if that means bypassing Medicare reimbursement for now. More than 270 hospitals in more than 120 health systems follow that model, with the CMS waivers remaining in place until the end of 2024. Lobbying efforts are underway to make those waivers permanent, but the uncertainty of continued Medicare support affects how health systems map out scalability and sustainability.
Why it’s important – While many hospitals are following the CMS model for Medicare reimbursement, others are trying their own ideas, mixing virtual and in-person care to target specific care gaps or populations. Confusing state laws and the uncertain future of the CMS model will continue to inspire health leaders to develop their own strategies for delivering care at home.
First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study
Why it’s important – Quoting from the article: “This device may offer a completely new way of measuring chronic heart failure,” said Nir Uriel, MD, National Principal Investigator for the study and Director of Heart Failure, Heart Transplant, and Mechanical Circulatory Support programs at New York-Presbyterian. “The data gathered outside of the U.S. has been promising, and we look forward to studying its use in the U.S.”
What happened in health care technology this week, and why it’s important.
This wearable AI device reads your sweat to tell you about your heart’s health
The Jerusalem Post’s Zachy Hennesey begins the coverage this week. YOPI Technologies, an Israeli hi-tech company founded by experienced entrepreneurs Hemi Re’em and Dr. Menachem Genut, has successfully completed the development phase of YOPI, a wearable AI-based device designed to monitor sweat and detect early signs of heart function deterioration. YOPI (an acronym for “Your Online Personal Instructor”) represents a significant innovation in sports monitoring and heart health tracking. Worn on the arm, the device incorporates a unique sensor developed by the company to allow for online tracking of training intensity and personalized physiological adjustments.
Why it’s important – The developers contend that this wearable device will allow continuous monitoring of heart health and sports medicine.
Infographics of the week – Dr. Bertalan Meskó and his team at The Medical Futurist Institute have compiled a comprehensive #ChatGPT prompt engineering cheat sheet. With this resource, you’ll find explanations of key terms, along with 10+1 invaluable tips accompanied by illustrative examples. These tips will undoubtedly enhance your proficiency in prompt engineering and maximize your utilization of ChatGPT’s capabilities. Furthermore, the cheat sheet talks a bit about the limitations of ChatGPT and sheds light on the best plugins currently available. So you’ll not only gain insights on how to optimize your interactions but also discover the best tools to augment your experience. Great tool!
The second infographic is from Dr. Tazeen Rizvi. In today’s connected world, mobile devices have become ubiquitous, including digital wearables that provide real-time information on physical activity, heart rate, sleep, oxygen saturation, and other clinical parameters. Digital wearables are continuously evolving to monitor specific health concerns to present valuable data for disease monitoring. As the penetration of these devices increases, more health data can be integrated into clinical and research settings. Effectively leveraging the potential of remote monitoring tools can truly democratize healthcare, bring quality care at lower costs, improve access, and allow early intervention to drive preventive models of care to advance public health meaningfully.
New Generative AI App Measures Vital Signs Through A Selfie
HIT’s Syed Hamza Sohail reports that Dr. Renee Dua and Nick Desai — who previously founded and built visionary doctor house call company Heal — introduced Together by Renee, the first app to use generative AI to complete and manage cumbersome healthcare tasks for aging adults, those with chronic diseases and their overwhelmed caregivers. Together is the first U.S. app that measures vitals, including blood pressure, heart rate, heart rate variability, respiratory rate, and blood oxygen, just by having users smile for a selfie, a breakthrough in ease and usability. This device less, hassle-free “always with you” ability to track vitals is invaluable both for those with chronic diseases and worried caregivers, who can make sure their loved ones are doing well from far away.
Why it’s important – The Annals of Internal Medicine reports that less than 50% of adults take all their medications correctly. The Centers for Disease Control and Prevention states that less than 10% of adults get necessary preventive exams, and stunningly, the Agency for Healthcare Research and Quality reveals that less than 15% of adults even have the health literacy to assist in their own care. Together uses AI to know their doctor’s name, determine when the user needs an appointment, and then uses voice AI to automatically call the doctor’s office, schedule the appointment for the user and add it to their calendar.
Podcast of the week – From Sg2’s Perspectives podcast series, they discuss clinically integrated networks (CINs) with Sg2 Associate Principal Joseph Maher. Joe outlines how CINs have evolved; their challenges and advantages; and how they can help improve health outcomes, patient experience, and costs. You can listen to the episode here.
Harmonizing Recovery: Robotic Glove Helps Stroke Survivors Relearn Music
From Neuroscience News comes this story about a ‘smart hand exoskeleton,’ a custom-made robotic glove that can aid stroke patients in relearning dexterity-based skills like playing music. The glove, equipped with integrated tactile sensors, soft actuators, and artificial intelligence, can mimic natural hand movements and provide tactile sensations. The ‘smart hand exoskeleton,’ weighing just 191g, features soft pneumatic actuators and an array of 16 flexible sensors, mimicking natural hand movements and providing tactile feedback. The glove’s design was taught via machine learning to discern correct from incorrect piano play, showcasing its potential in helping stroke patients relearn music and other complex tasks.
Why it’s important – Stroke is the most important cause of disability for adults in the EU, which affects approximately 1.1 million inhabitants each year. After a stroke, patients commonly need rehabilitation to relearn to walk, talk, or perform daily tasks. The authors foresee that patients might ultimately wear a pair of these gloves to help both hands independently to regain dexterity, motor skills, and a sense of coordination. Challenges remain, however. These include improving the accuracy and reliability of tactile sensing, enhancing the adaptability and dexterity of the exoskeleton design, and refining the machine learning algorithms to better interpret and respond to user input.
Apple’s Vision Pro: The dawn of screenless computing is upon us – opinion
Brian Blum’s opinion piece in The Jerusalem Post contends that what most pundits have gotten wrong about the Vision Pro is that it’s not about virtual reality at all. It’s the dawn of screenless computing. Apple will undoubtedly pursue its standard new product playbook. “Start with a 1.0 version that’s equally praised and damned for its differentness. Then keep fixing, fixing, fixing over the years, chipping away at the specs, features, and cost,” until the product is a hit.
Why it’s important – I think Blum’s on to something here. Apple is positioning the Vision Pro as a productivity device more than as a new piece of hardware on which to play games. The Vision Pro is not there yet. At $3,500, it’s a long way from a mass-market consumer product. And it won’t even be released until 2024. Give it a few years. Remember Apple’s track record. Let’s not forget that the first version of the iPhone had no GPS, no front-facing selfie camera, and not even an app store. Let’s not forget how the naysayers went after the iPad – “who needs something that’s bigger than an iPhone but less functionality than a laptop? There’s no market,” the pundits cried – before directing their ill-fated ire on the Apple Watch. Apple now makes the world’s most popular smartwatch.
This Stanford professor developed a new form of chemistry. Now she’s deploying it against cancer
Fast Company’s Adam Bluestein interviews Carolyn Bertozzi, who says, “I had no idea people would have to pronounce this when I coined it—it’s a mouthful!” of the term she invented to describe the scientific breakthrough that won her the 2022 Nobel Prize in Chemistry (shared with Morten P. Meldal and Karl Barry Sharpless). “Bioorthogonal” chemistry refers to methods of performing chemical reactions inside living cells, animals, or people—rather than in beakers, flasks, and test tubes. “In the 1990s,” she explains, “we had all these ideas for ways you could study biology and make new medicines if you could design reactions where the chemicals totally ignore the biological system, but when they see each other, boom, they react. ‘Orthogonal’ means ‘no interaction,’ so ‘bioorthogonal’ means ‘no interaction with biology.’”
The technology can be used in medical imaging—attaching chemical markers to a tumor, for example, so that it’s visible in a scan. Or it can be used to append a chemical target to particular cells to help deliver a drug or radiation that becomes active only where it is needed. Bertozzi’s lab at Stanford currently uses bioorthogonal chemistry to study sugars that are produced on the surface of cells (a discipline called glycobiology) and show how they can shield cancer from the immune system.
Why it’s important – It’s an area of biology that’s been overlooked. But it is central to cancer and inflammatory and autoimmune diseases, too. An experimental drug based on this research, which works “like a lawn mower” to cut the sugar “camouflage” off cancer cells, is in Phase 1 clinical trials and was developed by Palleon Pharmaceuticals, where Bertozzi is a co-founder. She hopes that “glyco-immunology” will improve outcomes for the majority of patients who don’t respond to current immunotherapies.
AI Could Find Best Meds for High Blood Pressure
A new artificial intelligence program may help doctors better match people with high blood pressure to the medication most likely to work for them. Boston University posted this research on Futurity online. The new data-driven model aims to give clinicians real-time hypertension treatment recommendations based on patient-specific characteristics, including demographics, vital signs, past medical history, and clinical test records. The model, described in a study published in BMC Medical Informatics and Decision Making, has the potential to help reduce systolic blood pressure—measured when the heart is beating rather than resting—more effectively than the current standard of care.
Why it’s important – For the nearly half of Americans with hypertension, it’s a potential death sentence—close to 700,000 deaths in 2021 were caused by high blood pressure, according to the US Centers for Disease Control and Prevention. It also increases the risk of stroke and chronic heart failure. The new model generates a custom hypertension prescription using an individual patient’s profile, giving physicians a list of suggested medications with an associated probability of success. The researchers aimed to highlight the treatment that best controls systolic blood pressure for each patient based on its effectiveness in a group of similar patients. In the past, machine learning in health care has also been hampered by incomplete or inaccurate data, as well as sparse patient histories, which can skew prediction results. An essential aspect of this study was to ensure data was transparent and that clinicians—particularly those without technical expertise—clearly understood how the algorithm worked and how and why the model proposed specific therapeutic recommendations.
$400M Apple Face ID inventors create tiny robot to treat brain disease
Matthew Kalman in The Times of Israel reports that Bionaut Labs is testing its technology at a Mayo Clinic facility and is poised to begin clinical trials with five top-tier US medical centers as it applies for FDA approval. Bionaut is currently raising a Series B-1 funding round, as featured on the OurCrowd investment platform. The company’s Bionaut, a tiny micro-robot smaller than a grain of rice, is guided through a patient’s central nervous system into a targeted spot in the brain where it can perform minor surgery, deliver therapeutic drugs, or return with tissue for a biopsy.
Why it’s important – Pharma giants are targeting a wide range of neuro-degenerative conditions, including Parkinson’s, Huntington’s, Alzheimer’s, epilepsy, glioblastoma, and many more. Still, they all face the challenge of getting the drugs to the point where they are needed inside the brain. The Bionaut, guided by a physician using a powerful magnet, can release a payload of targeted therapy directly into a tumor or any other localized target– even deep inside the brain – and head for home. A Bionaut can carry a therapeutic payload and deliver it directly to the targeted area, which avoids flooding the entire central nervous system. Instead of drilling through several centimeters of brain tissue, the Bionaut can be guided through internal fluids to within millimeters of its target.
“For AI to add the most value and for patients and physicians to embrace it, it needs to support, not supplant, the patient-physician relationship … AI will be most effective when it enhances physicians’ ability to focus their full attention on the patient by shifting the physicians’ responsibilities away from transactional tasks toward personalized care that lies at the heart of human healing.”
Steven Lin, MD, Vice Chief of Technology Innovation, Stanford University
Generative AI like ChatGPT is truly exciting, and it’s easy to be seduced by the technology’s potential to produce, well, almost any sort of output. Be careful. The opportunity in generative AI is enormous but requires a thorough analysis of where the best applications lie. Healthcare, in particular, needs this assessment – this isn’t an industry known for fast change, and the risks of inappropriately deploying new technology can be huge. For instance, consider the hype around IBM’s Watson Health a few years ago; this AI was going to figure out complex cancers! It didn’t, and it was sold off cheaply in parts last year.
Few industries are as data-rich, text-heavy, and in critical demand for automation as healthcare. Beyond these attributes, there is sharp information asymmetry that exists both for patients and for clinicians; patients want to be better informed about their health, and clinical teams yearn for more timely, easily accessible insights on their patients and populations to better inform their delivery of healthcare.
In this context, generative AI models, particularly LLMs such as GPT-3.5 (and others such as Google’s PaLM) and derived technologies, such as chatGPT, can potentially transform healthcare. On the patient side, generative AI can generate rich, accurate medical advice and information (from multiple independent sources) to better inform and educate patients on their condition or symptoms. On the clinician side, generative AI can potentially reduce the administrative burden on clinicians, for example, by automating tasks such as writing referral letters, clinical coding, and the summarization of clinical consultations.
With a market opportunity worth a colossal $6 trillion, according to Morgan Stanley, it’s impossible to ignore the impact that this technology is set to have. Generative AI isn’t just a passing trend; it’s a rapidly evolving ecosystem of tools growing in popularity and showing tremendous potential to revolutionize healthcare in ways we’ve never seen before. This technology encompasses much more than just ChatGPT and can handle various data types, including text, images, audio, video, 3D modeling, and even coding. While some estimates suggest that it could even raise global GDP by 7% over 10 years, the potential applications of generative AI go well beyond just economic gains.
Exploring the potential use cases
There are several ways to segment the potential use cases for generative AI in healthcare. Boston Consulting Group (BCG) did one excellent approach in their June 2023 analysis of the state of the market.
For each segment—providers, pharmaceutical firms, payers, MedTech, services and operations, and public-health agencies—they grouped the options into three categories: validated solutions already on the market, early-stage or conceptual use cases, and potential future use cases not yet in development. You can read their analysis and approach here.
While I like the segmentation described in the BCG research, I think that most healthcare organizations will look to a more straightforward approach to deploying generative AI to solve pressing issues where they can realize immediate benefits. Generative AI is evolving at record speed while CEOs are still learning the technology’s business value and risks. Hospital CEOs tend to share three core business challenges: Negative margins, staff recruitment and retention, and staff burnout. What if generative AI could remove administrative and documentation burdens, help with the pre-op workflow, and assist with appealing claims denials? Many potential low-risk use cases could result in more time clinicians spend with patients. I offer some potential initial use cases to consider.
First, go after operational efficiencies – A study by the National Bureau of Economic Research found that access to a generative AI-based conversational assistant increases workers’ productivity by 14% on average, “as measured by issues resolved per hour.” Healthcare providers can reduce the administrative burden by implementing generative AI for various use cases, including enhancing member communications through digital channels and acting as a physician scribe. Using generative AI systems, physicians can automate the extraction of medically relevant information from discussion recordings, summarize the interaction and integrate notes into EHR systems. This can result in improved physician productivity and increased accuracy of patient data. Providers can also lower costs and offer improved member experience because generative AI enables more personalized and proactive communications through virtualagents (chatbots).
Generative AI use cases can impact capabilities across the payer value chain. As in the case of providers, communication through digital channels like chatbots can be significantly enhanced by tapping into the knowledge base of the payer, including policy documents. Generative AI can also be used to auto-generate approval and denial letters—this would encompass supporting responses to prior authorization requests and claim requests to improve speed and effectiveness.
Next, I’d look at clinical decision–making – Generative AI is already assisting doctors and medical professionals in making accurate and informed diagnoses. Generative AI can analyze data from a patient’s medical records, lab results, previous treatments, and medical imaging, such as MRIs and X-rays, to identify potential problem areas and suggest further testing or treatment options. One example proving this ability is Glass.Health who have created a generative AI tool capable of generating diagnoses and clinical plans based on the input of symptoms. By integrating data traditionally in the electronic health record (EHR) and data from outside the EHR, like social determinants of health and social networking data, generative AI algorithms could help identify chronic diseases earlier to improve health outcomes. This could help healthcare providers make more accurate and timely diagnoses, leading to earlier treatment and better patient outcomes.
Third, I’d look at personalized medication management and home care – The ability to provide customized care is essential in today’s healthcare landscape. Wearable devices can collect real-time, continuous data on a patient’s health indicators, including heart rate variability, blood oxygen, and blood glucose levels. The data can then be fed into generative AI algorithms, which can analyze and interpret the data and offer tailored recommendations and treatment options. In this way, AI would be deployed to manage diseases detected by wearables, like cardiovascular disease, for example. By leveraging wearables and at-home monitoring devices with generative AI, healthcare providers can move away from the traditional, reactive healthcare model to a proactive one.
Finally, I’d explore risk prediction and pandemic preparedness – According to National Geographic, there are more viruses in existence than stars in the universe, and on average, approximately two new species of human viruses emerge yearly. As we have seen with the recent global pandemic, a new human-to-human virus without prior immunity could rapidly escalate into a pandemic, leading to millions of fatalities. Generative AI models have emerged as a vital source of insights for scientists studying the societal-scale effects of catastrophic events, such as modeling new pandemics and developing preventive measures. For instance, new generative AI models are being trained on large amounts of protein sequences to identify new antibodies which could address infectious diseases and support outbreak response.
What should we worry about? – While there are many potential benefits to using generative AI in healthcare, there are also some possible challenges and drawbacks. Some examples include:
Privacy and security: Patient privacy is strictly regulated. The use of generative AI in healthcare also raises concerns about protecting patient privacy, sensitive medical data, and the potential for misuse or unauthorized access to the healthcare data.
Bias and discrimination: Generative AI algorithms can be prone to bias and discrimination, especially if they are trained on healthcare data not representative of the population they are intended to serve. This can result in unfair or inaccurate medical diagnoses or treatment plans for underprivileged groups such as women or non-white races.
Misuse and over-reliance: If generative AI algorithms are not used properly, they can lead to incorrect or harmful medical decisions. In addition, there is a risk that healthcare providers may become overly reliant on these algorithms and lose the ability to make independent judgments.
Ethical considerations: Using generative AI in healthcare raises several ethical concerns, such as the potential impact on employment in the healthcare sector.
What questions should leaders ask? – In health systems considering generative AI, executives will want to quickly identify the parts of their business where the technology could have the most immediate impact and implement a mechanism to monitor it, given that it is expected to evolve quickly. A no-regrets move is to assemble a cross-functional team, including data science practitioners, legal experts, and functional system leaders, to think through essential questions such as these:
Where might the technology aid or disrupt our industry and/or our system’s value chain?
What are our policies and posture? For example, are we watchfully waiting to see how the technology evolves, investing in pilots, or looking to build a new service? Should the posture vary across areas of the system?
Given the limitations of the models, what are our criteria for selecting use cases to target?
How do we pursue building an effective ecosystem of partners, communities, and platforms?
What legal and community standards should these models adhere to so we can maintain trust with our stakeholders?
Who’s applying generative AI in healthcare today? – The University of Kansas Health System is rolling out generative AI throughout its Kansas City-area medical centers. In one of the earliest large-scale uses of generative AI, the system is making Abridge AI Inc.’s application available to its 1,500 physicians and other clinicians. At UPMC, a minority investor in Abridge, a small cohort of clinicians uses technology from Abridge to document interactions with patients automatically. Abridge “listens” to conversations between a patient and their health care provider and extracts the critical points, like a change in medication or behavior, and creates notes for the patient and the electronic record (EHR). So far, both patients’ and clinicians’ reactions have been positive. UNC Health, meanwhile, is another early adopter. It has agreed to participate in a much smaller generative AI pilot with EHR giant Epic. The initial rollout will begin with five to 10 physicians at UNC Health using the technology to auto-draft responses to common patient questions that are time-consuming to answer. UC San Diego Health, UW Health, and Stanford Health Care also are participating in the pilot.
What’s next for generative AI – While the emergence of generative AI is exciting for many in the healthcare industry, it’s natural for others to feel nervous and uncertain of its future. Nevertheless, the potential for revolutionary progress within healthcare is undeniable. As such, the choices made by healthcare providers, practitioners, policymakers, and other stakeholders in the coming years will be critical in shaping the evolution of this technology.
As with any innovation, we must approach generative AI cautiously, acknowledging that its impact could be transformative, provided we adapt to its unique challenges and opportunities. Moments like this don’t come around often. A future marked by generative AI technology will usher healthcare into a new era of innovation, and those daring to experiment and lead in this space will help create opportunities for patients, providers, and healthcare institutions alike.
What happened in health care technology this week, and why it’s important.
Survey: Employers Aren’t Doing Enough To Support Employees’ Mental Health
A Northeast Business Group on Health survey published Monday found that 26% of employers never identify the needs of employees nor the “awareness and effectiveness” of their mental health programs. About three in ten respondents don’t have messaging campaigns through social media and internal platforms on mental health. Maria Plescia provides the details in her MedCity News article. The Northeast Business Group on Health survey, published Monday, found that 26% of employers never identify the needs of employees nor the “awareness and effectiveness” of their mental health programs. About three in ten respondents don’t have messaging campaigns through social media and internal platforms on mental health.
The survey included responses from 140 large employers in the U.S. It used a tool Northeast Business Group on Health launched in November called Well Gauge. The tool asks participants a series of questions through four sections: communicating a commitment to mental health, engaging leadership at all levels, demonstrating a commitment to mental health, and fostering environments that support total health. Users of the tool also receive recommendations to improve mental wellness support at their organization.
Why it’s important – The survey shows that while employers know that mental health support is vital, more work needs to be done. Based on these findings, employers need to help reduce the stigma around mental health and show that the company cares. Additionally, leaders need to ‘walk the talk’ and demonstrate they are engaged in supporting their employees and their own mental health to help normalize conversations around mental health.
Infographics of the week – KFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go Without or Delay Care – Most (58%) people with health insurance say they encountered at least one problem using their coverage in the past year, with even larger shares of people with the most significant health care needs reporting such problems, finds a new KFF survey of consumer experiences with health insurance.
What if the ambulance doesn’t come? Rural America faces a broken emergency medical system
Nada Hassanein, a national correspondent at USA TODAY, reports that as rural hospitals shutter across the nation, dwindling emergency medical services also must travel far to the nearest hospital or trauma center. Experts and those in the field say EMS needs a more systematic funding model to support rural and poorer urban communities. Few states designate EMS as essential services. In the U.S., local governments mainly fund EMS, and not all states allocate supplemental funds toward the services.
Why it’s important – Nearly 4.5 million people across the U.S. live in an “ambulance desert” – 25 minutes or more from an ambulance station – and more than half of those are residents of rural counties, according to a new national study by the Maine Rural Health Research Center and the Rural Health Research Centers. As rural hospitals shutter across the nation, dwindling emergency medical services also must travel far to the nearest hospital or trauma center.
Podcasts of the week – This week’s recommendation is Device Weekly’s episode featuring Mike Favet, CEO of NeuroPace, who talks about how the company’s RNS technology is helping to transform the lives of patients with drug-resistant epilepsy. NeuroPace, one of the pioneers in neurostimulation, has the only FDA-approved neurostim treatment for epilepsy. Favet took over as CEO four years ago from the founding CEO, so we discuss his background, the changes he made at the company, and how NeuroPace is building a market for a medical device to treat a disease that typically can be managed only by pharmaceuticals. You can listen to the episode here.
My second Podcast recommendation this week is a special program on the ‘NMP’ Problem in Medicine. NMP stands for ‘not my patient, not my problem,” an infection in medicine so broad and so deep that even the best of the best develop blind spots (implicit or confirmation bias) while we, the patient, often pay a very steep price. In this case, Greg Masters’ son Anthony John Masters may be its latest victim. Host Gil Bashe interviews his colleague and executive producer of Health UnaBASHEd on the untimely and avoidable death of his 38-year-old son Anthony John Masters.
The iPad was meant to revolutionize accessibility. What happened?
For people who can’t speak, there has been depressingly little technological innovation that helps them communicate. Julie Kim, in MIT Technology Review, reports on her research into augmentative and alternative communication (AAC) technology for her daughter, who is five years old and also non-speaking. Underwhelmed by the available options—a handful of iPad apps that look (and work) as if they were coded in the 1990s—I’d delved into the speculative, more exciting world of brain-computer interfaces. Because the reality is this: the last significant advance in AAC technology happened 13 years ago, an eternity in technology time. On April 3, 2010, Steve Jobs debuted the iPad. What for most people was a more convenient form factor was something far more consequential for non-speakers: a life-changing revolution in access to an attractive, portable, and powerful communication device for just a few hundred dollars. Like smartphones, iPads had built-in touch screens, but with the critical advantage of more space to display dozens of icon-based buttons on a single screen. And for the first time, AAC users could use the same device they used for speaking to do other things, like text, FaceTime, browse the web, watch movies, record audio, and share photos.
Why it’s important – A piece of hardware, however impressively designed and engineered, is only as valuable as what a person can do with it. After the iPad’s release, the flood of new, easy-to-use AAC apps that LoStracco, Shevchenko, and their clients wanted never came. Today, there are about a half-dozen apps, each retailing for $200 to $300, that rely on 30-year-old conventions asking users to select from menus of crudely drawn icons to produce text and synthesized speech. Beyond the high price point, most AAC apps require customization by a trained specialist to be helpful. This could be the reason access remains a problem.
There aren’t many other options available, though the possibilities do depend on the abilities of the user. Literate non-speakers with complete motor control of their arms, hands, and fingers, for example, can use readily available text-to-speech software on a smartphone, tablet, or desktop or laptop computer. Those whose fine motor control is limited can also use these applications with the assistance of an eye-controlled laser pointer, a physical pointer attached to their head, or another person to help them operate a touch screen, mouse, or keyboard. The options dwindle for pre-literate and cognitively impaired users who communicate with picture-based vocabularies.
YouTube video of the week – From this year’s Aspen Ideas Festival, from revolutionary advancements aiding paralysis patients to the therapeutic treatment of PTSD, brain-computer interfaces (BCIs) possess the boundless potential for merging human biology with cutting-edge technology in unprecedented ways. Three visionaries in this field demonstrate what’s possible now and offer insights into the future trajectory of this technology.
The Best ChatGPT Plugins: How To Add Browsing, Learning, Wolfram And More
Andrea Koncz from The Medical Futurist Institute provides this overview of the new plugin universe. ChatGPT plugins are like additional apps, enhancing the AI’s skills. They can be added from the “plugin store” and offer a wide range of features, from work-related tasks to games and lifestyle assistance. She notes that privacy risks associated with these plugins require careful attention, especially with plugins accessing personal information or accounts.
Why it’s important – Despite the current limitations, these plugins represent a glimpse into the future of AI technology, showcasing possibilities for a more personalized and versatile AI assistant. They are in the early stages of development and make mistakes—lots of them. Remember that they are imperfect, so use their outputs with a good pinch of salt.
‘It’s like Groundhog Day’: The cancer drug shortage isn’t new — and neither are the solutions
The result is that many doctors, particularly those at smaller community clinics and hospitals, haven’t been able to give drug combinations that would have given many patients an excellent chance of a cure for their cancer.
Why it’s important – Providers have to switch to less-than-ideal regimens, which may overall be less effective in the treatment of their disease. Providers have to decide who gets what. We’ve had patients who are not only worried about their diagnosis, which is life-changing, but the emotional toll they get — feeling like maybe I’m not getting the best treatment for my condition. That’s a big deal.
How Can Health System Leaders Collaborate Efficiently When Adopting New Tech?
MedCity News’ Katie Adams reports that Health system executives discussed what these strategic conversations should ideally look like during a virtual panel Thursday, which was co-hosted by Matter and Avia. They stressed it is vital to assemble a diversified decision-making team and that leaders should prioritize addressing the organization’s challenges and opportunities rather than being captivated by flashy new products.
Why it’s important – When a health system considers rolling out a digital initiative or adopting a new technology, its C-suite leaders usually become involved in a circuitous decision-making process involving many stakeholders. For example, when drawing up implementation plans for a new digital tool, health systems often discover that their organization has a lot of unnecessary variation. In a situation like this, leaders should work to standardize the data points in their respective departments instead of ignoring the problem or hoping someone else can fix it. This type of responsibility and cooperation helps digital projects progress faster and more smoothly.
Healthcare costs to jump 7% in 2024: PwC
Healthcare costs will increase by a projected 7 percent in 2024 as the healthcare industry continues to face high inflation, rising wages, and other costs, which are compounded by workforce shortages, according to a report from the PwC Health Research Institute. Here are some of the highlights:
The 7 percent spike is higher than the projected medical cost trend in 2022 (5.5 percent) and 2023 (6 percent).
Key drivers of the cost growth include new gene therapies — which can cost millions of dollars — and the weight loss drug space, as well as increased consolidation among hospitals and other healthcare facilities.
Hospitals and physicians are expected to seek higher rate increases in contract negotiations. Workforce shortages and physician consolidation can further amplify the inflationary effects on providers, with burnout and rising patient demand expected to keep the pressure on clinical workforces across the U.S.
Payers are negotiating pricing with hospitals while provider profit margins continue to erode, according to the report. Health plans also feel the squeeze of higher median prices for new drugs and increasing prices on existing drugs.
Some positive changes in the pharmaceutical market and care setting — including biosimilars coming to market and care shifting to outpatient settings — are expected.
Many health plans continue to invest in the total cost of care management initiatives, such as value-based care, that helped maintain year-over-year trends, according to the report. National health plans generally demonstrated better cost management and subsequently achieved lower cost trends. As these national plans grow, they are projected to have a deflator effect overall on medical cost trends.
These are the areas that PwC will be following over the next year to track and forecast medical cost trend.
Why it’s important – The medical cost trend, or growth rate, is primarily influenced by changes in the price of medical products and services and prescription medications, known as unit cost inflation, and changes in the number or intensity of services used or changes in per capita utilization. We’re in an emerging age of omnichannel health care where many patients feel and act more empowered to shop for medical appointments (say, via ZocDoc), leverage digital front doors via telehealth or encrypted messages on patient portals with providers, and take advantage of tele-mental health therapy with counselors who were not so available pre-pandemic. While the cost of treating patients is rising, I do not doubt that the patient-as-payor will determine much of that spending. Click here to read the full report.
Have a wonderful Independence Day holiday!
“The happiness of America is intimately connected with the happiness of all mankind; she is destined to become the safe and venerable asylum of virtue, of honesty, of tolerance, and quality and of peaceful liberty.”
“Value-based care is the future of healthcare, but it’s complex and labor-intensive to deliver and scale. Uber Health addresses this challenge head-on. Our platform streamlines coordination across multiple benefits—non-emergency medical transportation, prescription delivery, and food and over-the-counter medication delivery, empowering payers and providers to support patients beyond the four walls of a medical office. And, because our platform is built on the largest mobility network in the world, we’re uniquely capable of meeting these needs and unlocking the potential of value-based care at scale.”
Caitlin Donovan, global head of Uber Health
One of the key recognized impediments in healthcare is access to care. Often, when this issue is discussed, it devolves into a conversation regarding how communities don’t have enough physicians or healthcare services, how there isn’t an easy way for people to get the care they need, etc. While these are incredibly important topics, another critical issue rarely gets discussed: the logistics of accessing care.
Millions of Americans do not have the means to physically get to the hospital or physician themselves—that is, they have to rely on public transportation, relatives or friends, or other external variables to ensure they can access healthcare services promptly. Both Lyft and Uber saw an opportunity in this problem: provide an easier way to acquire non-emergency medical transportation (NEMT).
Since 2018, Uber has worked with health plans in the US, mainly behind the scenes, to offer services to members, like transportation, particularly for the elderly on Medicare plans and those on Medicaid plans serving low-income Americans. It’s also delivered medications. Now, Uber is adding groceries and over-the-counter medical items to its Uber Health services. The program, in beta testing now, aims to be in place for health plans in 2024. It would allow healthcare professionals to prescribe groceries or meals to people, as well as over-the-counter medical items. Anyone from a doctor to a care coordinator can log on to Uber’s health platform and determine which patients might need groceries or restaurant delivery and get them sent to the patient.
Uber is the latest company to bet big on prescribing food to prevent higher medical costs. Instacart in March launched digital tools to allow doctors to prescribe food the way they might prescribe a medication. Meanwhile, companies like Kroger and investors like Andreessen Horowitz are betting big on the approach. Healthier eating habits could reduce the need for some medicines to treat chronic conditions like diabetes or heart disease or prevent them from progressing to the point where a person needs additional medications or care. Healthier eating members could have significant financial implications for insurers. One study published in October found that insurers could save $13.6 billion in annual medical spending and prevent 1.6 million hospitalizations by providing meals tailored to an individual’s needs.
Then there’s Lyft
Although the popular ride-sharing app Lyft Inc. (Nasdaq: LYFT) was formed in 2012, Buck Poropatich considers 2016 a turning point for the company. That’s when company leaders decided to take a look at health care. Lyft’s healthcare strategy puts the company squarely within home-based care. It has partnered in the space for years with companies such as Right at Home, Comfort Keepers, and Humana Inc. (NYSE: HUM). The company’s objective in the area is not to disrupt it but to find a specific niche within it. Poropatich cited a recent study from the Robert Wood Johnson Foundation that found 5% of American adults reported forgoing health care in 2022 due to transportation barriers.
Poropatich believes Lyft can help patients get to healthcare appointments outside their homes. At the same time, he thinks it can help get caregivers and clinicians to those at-home visits while also reducing windshield time for them. Ultimately, Lyft wants to reduce costs, improve convenience and enhance accessibility for patients and its partners.
Uber and Lyft use a B2B model, allowing partner healthcare providers to use their platforms in API or website form. This will enable doctors to schedule rides in advance or in real-time for patients, with no smartphone necessary. Each month, Uber charges the healthcare provider, which then either covers the cost or passes it along to insurance companies or patients directly.
Lyft has partnered with many of the largest U.S. healthcare systems and insurance providers, such as Blue Cross Blue Shield, Humana, and Allscripts, reaching tens of millions of patients. In the Bay Area, that includes Sutter Physician Services, UCSF, Dignity Mercy General, El Camino Hospital, and more. Uber wants to use its grip on the U.S. market to compete with global aspirations down the pipeline. Already the rideshare company has partnered with its share of small and large healthcare operators, including MedStar, Boston Medical Center, and 123 Home Care, which uses the services also to transport its caregivers. Recent data shows that Uber now has over 3,000 healthcare clients.
Beyond Uber and Lyft, hospitals and healthcare systems are working on their homegrown transportation options, too, as they seek to tailor transit capacities to communities that encompass other challenges, such as getting child care.
Using Uber and Lyft for Clinical Trials
Clinical trials continue to struggle with patient engagement, which has a tangible impact on the cost of care globally; approximately 27% of the more than $7 billion spent on clinical trials in the U.S. can be attributed to patient recruitment and enrollment. Moreover, every day of delay during the development process represents up to $1 million in potential revenue loss for the trial sponsor. With such high stakes, it’s unsurprising that the industry is starting to think outside the box to improve patient engagement in clinical studies.
To address these issues, a number of sponsors and CROs are beginning to partner with ridesharing services — Brownstein launched Circulation (spun out of Boston Children’s Hospital in 2016 with more than $10M in venture capital funding and sold, two years later, to Logisticare for $58M), which leverages Uber technology that not only gets patients to trial sites but also allows trial organizers to coordinate the rides themselves and monitor where patients are in real-time. Lyft is dabbling in similar ventures. They have a partnership with Continuum in which they’ll be offering free transportation to eligible patients enrolled in trials with their partners.
Why this is important
We’re now seeing more and more partnerships leveraging consumer-facing services and technologies to improve efficiency. The Uber Health website states, “We help complete the picture of care for healthcare organizations.” As the home becomes a more important site of care, using partnerships that have the scale, infrastructure, and competence to address critical social determinants of health like travel issues, access to medicines, and food insecurity can support and accelerate the efforts of health systems, businesses, and payers to move to genuine value-based care. As a result, patients and their families will benefit from better access, lower costs, and better outcomes – worthy goals by anyone’s standards.
What happened in health care technology this week, and why it’s important.
Wrist-worn wearable could detect sickle cell pain episodes
Nick Paul Taylor begins the coverage this week with his article in MedTech Dive. He reports that a wrist-worn wearable could provide early warning of the severe acute pain episodes that affect patients with sickle cell disease. Researchers at Children’s Hospital Los Angeles (CHLA) tested the idea that the narrowing of blood vessels predicts the events in a clinical trial that reported data in 2019. They partnered with Biostrap to develop the blood flow biomarker that year. The studies showed that photoplethysmography (PPG), a way to measure changes in blood volume used in pulse oximeters, can predict the painful vaso-occlusive crises affecting sickle cell patients. PPG monitors blood volume by measuring changes in light absorption, and the researchers used the technology to record the median magnitude of vasoconstriction (Mvasoc).
Why it’s important – Wrist-worn wearables could make Mvasoc more useful for people with sickle cell disease. Rather than manually attaching a sensor, patients could wear a device on their wrist and automatically collect Mvasoc data. That thinking led the researchers at CHLA to partner with Biostrap in 2021. Researchers hope the wearable will be able to detect the onset of a pain crisis days before the patient feels it. That early detection would be vital for administering medications or other interventions early, lowering the risk of severe pain or complication, or hospitalization.
Infographics of the week – To provide a clear contrast between the old and the new, Dr. Bertalan Meskó and his team at The Medical Futurist Institute collated data from numerous sources into an infographic that outlines the differences between traditional drug-based therapies and digital therapeutics. Digital therapeutics are more than just a novel concept. They hold the promise of improved health outcomes, greater accessibility, and cost-effectiveness in patient care when used based on proper evidence.
2023 Scorecard on State Health System Performance – Every year, the Commonwealth Fund’s Scorecard on State Health System Performance uses the most recent data to assess how well the health care system works in every U.S. state. This year, Massachusetts achieved the best overall score, consistently placing among the top states on the seven dimensions of health system performance we evaluate. Hawaii, New Hampshire, Rhode Island, and Vermont round out the top five. The lowest-ranked states overall are Arkansas, Texas, Oklahoma, West Virginia, and Mississippi.
Continued declines in screening mammogram volumes could have ‘worrisome implications,’ experts warn
More than three years after the height of COVID, the volume of screening mammograms still has not returned to pre-pandemic levels, according to new data from Brigham and Women’s Hospital. Health Imaging’s Hannah Murphy reports that a group of experts from the hospital recently analyzed screening trends there in the years leading up to and following the onset of COVID. They observed a persistent decrease of five monthly screening mammograms beginning in June 2021. In contrast, between October 2016 and March 2020, the group noted a steady increase of 65 screenings per month. The group’s findings also highlighted a shift in screening locations, with outpatient clinic screenings increasing from 35.8% before COVID to just under 45% in the years following.
Why it’s important – While the long-term effects of declining screening mammogram rates are not yet fully understood, the group cautioned that there could be “worrisome implications for the future of breast cancer diagnosis and treatment” to come if rates do not improve. The study abstract is available in Clinical Imaging.
YouTube Video of the Week – From Alex Lindsay and Office Hours comes this inaugural episode of Accessibility Hours, where they will begin a series of discussions around disabilities and learn from people with lived experiences, their work, and the barriers they face in various aspects of life. You will gain insights into the importance of inclusivity and accessibility and how we can create a more equitable society for individuals with disabilities. Engage in thought-provoking conversations and discover practical ways to foster a more inclusive environment. This is one of the most comprehensive conversations around accessibility and inclusion I’ve ever seen. Well worth viewing for anyone creating online and in-person meetings, conferences, and conversations.
Israeli researchers reach ‘breakthrough’ in fight against skin cancer
Why it’s important – Melanoma, the deadliest of all skin tumors, starts with the uncontrolled division of melanocyte cells in the epidermis – the top layer of the skin. In the second stage. the cancer cells penetrate the dermis and metastasize through the lymphatic and blood systems. In previous studies. a dramatic increase was observed in the density of lymph vessels in the skin around the melanoma – a mechanism researchers have not understood until now. Since melanoma is not dangerous at the premetastatic stage, understanding the mechanism by which the metastases spread via the lymphatic and blood systems could contribute to developing a vaccine against this deadly cancer.
FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy
Sarepta Therapeutics’ Elevidys is now the first FDA-approved gene therapy for Duchenne muscular dystrophy. Elevidys is an engineered version of a gene intended to restore function lost to the mutation at the root of the inherited muscle disease. Frank Vinluan covers the story in MedCity News online. FDA approval of the therapy, Elevidys, covers children ages 4 and 5, which is within the age range during which disease symptoms begin to appear. Those patients must have the ability to walk and a confirmed genetic mutation for the disease. Patients must also have no pre-existing medical reason that prevents them from receiving the therapy.
Why it’s important – The Duchenne muscular dystrophy drugs now available only treat the symptoms of the rare muscle-wasting disorder. Duchenne is caused by a mutation in the gene that codes for dystrophin, a protein that helps keep muscle cells intact. A deficiency of this protein leads to progressively worsening muscle weakness that manifests as walking and running difficulty, frequent falls, and fatigue. As the disease progresses, it affects the heart and lungs. Duchenne predominantly affects males, who typically live only into their 20s or 30s before succumbing to heart or respiratory failure. It’s important to note, however, that scientists detailed a long list of concerns with the company’s research, particularly a mid-stage study that the company submitted for FDA review. Overall, it failed to show that boys who received the therapy performed significantly better on measures like standing, walking, and climbing than those who got a dummy treatment. However, the results were better in younger kids.
Oura Will Now Share Its Sleep Scores With CGM Providers
Katie Adams reports that Oura — a company selling a ring that tracks peoples’ biometrics — announced new partnerships with three providers of continuous glucose monitors: January, Supersapiens, and Veri. These companies will now be receiving sleep scores and other biometric data from Oura so they can see how these measurements affect users’ glucose levels and overall health.
Why it’s important – Oura pursued these partnerships because glucose monitoring is a key piece of the overall picture of a person’s health. In the past, CGMs were primarily used by people with diabetes to monitor their body’s glucose levels. However, these devices are becoming increasingly popular with a broader audience nowadays — especially among people seeking to improve their athletic performance, lose weight or boost their energy levels. The new integrations could provide more insights into the relationship between sleep quality and blood glucose levels. Lack of sleep — specifically deep sleep — significantly reduces glucose tolerance and insulin sensitivity. Evidence also suggests that there might be a link between less-than-ideal sleep quality and impaired glucose metabolism.
Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could someday transform transplant medicine
From Stat’s Marion Renault comes this important research published this month. She describes the rat kidney as peculiarly beautiful — an edgeless viscera about the size of a quarter, gemstone-like and gleaming as if encased in pure glass. Then researchers at the University of Minnesota restarted the kidney’s biological clock, rewarming it before transplanting it back into a live rat — who survived the ordeal. In all, five rats received a vitrified-then-thawed kidney in a study whose results were published in Nature Communications. It’s the first time scientists have shown it’s possible to successfully and repeatedly transplant a life-sustaining mammalian organ after it has been rewarmed from this icy metabolic arrest.
Why it’s important – Outside experts unequivocally called the results a seminal milestone for the field of organ preservation. If researchers someday successfully translate those results into humans, experts told STAT, organ cryopreservation, and rewarming could revolutionize transplant medicine — and potentially save tens of thousands of lives each year in the U.S. alone. At any given moment, about 100,000 adults and children in the U.S. await a replacement organ. Last year, 41,225 got them. Each was dictated by time above all else: right now, doctors must sprint to obtain and then transplant organs within the tight, hours-long window they can stay alive outside the human body.
“I’d tell anyone who wants to be a podcaster, the same thing others have recommended – find a niche you’re passionate about and willing to be immersed in.”
Sandra Sealy, Chronicles Of A Seawoman: A Collection Of Poems
Since podcasting has become an essential channel for information sharing and learning, I thought I’d update the list of my favorite podcasts in health care and technology (and other topics) for your consideration.
With so many options, how do you select ones to listen to regularly? My first criteria are the credentials of the host. I want respected professionals in the field, not someone doing this as a sideline. Second, I look at the quality of the guests on the podcast. Can the host attract excellent guests in every episode? Finally, I look at the topics being discussed. Are they interesting? Do they add credible information to the conversation, or are they simply a rehashing of what’s already out there? So, with those as my guideposts, here are my favorite podcasts for 2023. (Click on the hyperlinks to access the podcast.)
The Heart of Healthcare with Halle Tecco – The Heart of Healthcare podcast gets to the heart of our mission in digital health — to massively improve healthcare for all. Halle Tecco is an entrepreneur and angel investor passionate about fixing our healthcare system. She founded Natalist (acquired by Everly Health), a digital health venture fund Rock Health, and co-founder / Chair of Cofertility. She is also an Adjunct Professor at Columbia Business School, teaching the first MBA-level course on digital health investing.
The Nocturnists Podcast – The Nocturnists is an award-winning, independent medical storytelling podcast hosted by physician Emily Silverman, which has featured the voices of over 450 clinicians in the United States and beyond. Since 2016, we’ve aired stories from our live performances, intimate audio diaries from healthcare workers, and insightful interviews with artists who tackle medical themes in their work. Through storytelling, we hope to humanize healthcare, support clinician well-being, and transform medical culture.
The #HCBiz Show! – As fascinating as cutting-edge med tech can be, Don Lee and Shahid Shaw, hosts of The#HCBiz Show, are less interested in the sparkly what of healthcare innovation. Instead, they focus on the less-sexy but arguably more important how and why. With technological advances changing our lives by the day, why is healthcare so slow to adapt? What stands between the lifesaving breakthroughs and their actual implementation in real-world healthcare situations?
Bright Spots in Healthcare Podcast – Who says there’s never any good news in the headlines? Well, maybe you don’t consider a podcast RSS feed “headlines.” Still, if you need a reason to feel good about where human ingenuity is taking us, Teledoc Health VP Eric Glazer has your monthly spoonful of sugar to help the medicine go down. In each episode, he interviews innovators in the healthcare industry to extract the strategies, tactics, tools, and routines they utilize to generate extraordinary, positive outcomes. They highlight and break down these bright spots so you can apply them at your organization. “See a bright spot …. and clone it!”
TEDTalks Health (Subscription required)- What does exercise do to your brain? Can psychedelics treat depression? From smart daily habits to new medical breakthroughs, welcome to TED Health with host Dr. Shoshana Ungerleider. TED speakers answer questions you never even knew you had and share ideas you won’t hear anywhere else, all around how we can live healthier lives.
Healthcare Executive Podcast – From The American College of Healthcare Executives, this series covers a wide array of information critical to the healthcare executive.
Healthcare Weekly – Healthcare Weekly puts technology at the center of a conversation about the healthcare industry—its successes and blind spots, what the past has taught us, and what promising innovations loom on the horizon. The hosts, digital entrepreneurs and consultants Codrin Arsene and Michael Reddy, interview leading innovators in health tech to discover how technologies like blockchain, artificial intelligence, and virtual reality are changing the face of medicine.
The Podcast by Kevin MD – Social media’s leading physician voice, Kevin Pho, MD, shares the stories of the many who intersect with our healthcare system but are rarely heard from. 15 minutes a day. Seven days a week.
I hope you find one or more of these podcasts interesting. If you have other suggestions, please let me know in the comments section. I’m always looking for new series to explore. And remember that these are additions to the podcasts I’ve recommended before. You can find those here and here. Enjoy!
What happened in health care technology this week, and why it’s important.
Study finds AI can predict cybersickness in VR users
Artificial Intelligence (AI) could be used to help combat nausea, headaches, and dizziness among virtual reality (VR) users and make the technology more accessible, according to a new study with Charles Darwin University (CDU). The study by CDU and Torrens University researchers explored using AI techniques and machine learning algorithms to predict cybersickness for potential users of VR technology with headsets.
Why it’s important – In the era of technology and especially after the COVID-19 pandemic, the need for remote access and virtual education has grown significantly. Cybersickness is one of the factors that hinder users from using VR devices because of the significant discomfort due to the VR experience.
Infographic of the week – We can expect a Great Reconsideration, or churn, among healthcare providers who fast-adopted and pivoted to telehealth and remote patient monitoring, based on new research of health execs from Panda Health and Sage Growth Partners. The team explored 24 digital health applications, with 11 shown here in The Churn Index table from the report. Note that telemedicine and e-visits, and remote monitoring, are expected to exhibit high “churn” as healthcare providers re-consider their early investments into these two areas and may seek to replace, strip out, or otherwise change vendor partners for these tools. Other areas, like patients’ ability to self-schedule and care coordination, are expected to essentially stay in place.
Doctors Are Using Chatbots in an Unexpected Way
Gina Kolata reports that despite the drawbacks of turning to artificial intelligence in medicine, some physicians find that ChatGPT improves their ability to communicate empathetically with patients in her New York Times article. In one survey, 85 percent of patients reported that a doctor’s compassion was more important than waiting time or cost. In another survey, nearly three-quarters of respondents said they had gone to doctors who were not compassionate. And a study of doctors’ conversations with the families of dying patients found that many were not empathetic.
Why it’s important – Skeptics like Dr. Dev Dash, who is part of the data science team at Stanford Health Care, are so far underwhelmed about the prospect of large language models like ChatGPT helping doctors. In tests performed by Dr. Dash and his colleagues, they received replies that occasionally were wrong but, he said, more often were not helpful or were inconsistent. If a doctor is using a chatbot to help communicate with a patient, errors could make a difficult situation worse. Still, those who have tried ChatGPT say the only way for doctors to decide how comfortable they would feel about handing over tasks — such as cultivating an empathetic approach or chart reading — is to ask it some questions themselves.
How Penn Medicine’s Telemedicine Program Saved It $113 Per Patient Visit
MedCity News reporter Katie Adams reports that Penn Medicine recently published a study in the American Journal of Managed Care on the economics of providing telemedicine — it showed that when the health system began offering virtual urgent care services to its employees, the visits ended up being 23% less expensive to conduct than in-person appointments. The study analyzed how much it costs to provide visits via Penn Medicine OnDemand — a 24/7 copayment-free telemedicine program that Penn Medicine established for its employees in the summer of 2017.
Why it’s important – Despite the growing availability of telemedicine programs provided by employers, many health systems have been hesitant to embrace this approach. One reason for this is that past research has shown that the cost of care is not reduced when employers offer telemedicine via third-party platforms, the study said. The study authors argued that health systems are uniquely positioned to establish homegrown, money-saving telemedicine programs — they can use the providers they already have, make in-system referrals, and coordinate better follow-up care.
YouTube videos of the week – Last week’s headlines were all about the entry of Apple into the consumer AR space with their VisionPro. But what about health? I shared some thoughts in my blog post about WWDC 2023. But this video from Dr. Atul Gupta, Chief Medical Officer of Philips Image Guided Therapy, is a terrific look at the potential for the technology in healthcare.
And here’s another great video summary from Dr. Rafael Grossmann from the NextMed Conference.
NYU Langone Health LLM can predict hospital readmissions
Researchers at New York University’s Langone Health academic medical center developed a large language model, now deployed at three of its hospitals, that predicts a patient’s risk of 30-day readmission and other clinical outcomes. Andrea Fox from Healthcare IT News reports that coinciding with its study published in Nature this week, the release of the NYUTron model’s code base in GitHub enables other healthcare organizations to train their own LLM and provide doctors with insights that could help them identify which patients may require intervention to reduce readmissions. The model has been used to evaluate 50,000 patients discharged from NYU’s healthcare system. NYUTron shares its predictions of readmission risk with physicians by email. NYU partnered with NVIDIA to develop and run its LLM on several of its artificial intelligence platforms – its stack, library, and software.
Why it’s important – Research published in the Journal of Multidisciplinary Healthcare last year said that nearly 15% of all hospital patients are readmitted to the hospital within 30 days after initial discharge. Readmission rates are affected by countless variables – including five common treatments at emergency departments – that not only impact a patient’s overall care but they can also divert beds and resources from patients that may have more intensive healthcare needs. “Not all hospitals have the resources to train a large language model from scratch in-house, but they can adopt a pre-trained model like NYUTron and then fine-tune it with a small sample of local data using GPUs in the cloud,” said Dr. Eric Oermann, assistant professor of neurosurgery, radiology, and data science at NYU Langone Health, said in a blog post on NVIDIA’s website.
Recommended video – There have been multiple articles on the use of large language models in healthcare recently. One of the annual conferences I follow is the World Medical Innovation Forum, held in Boston. They just posted a video of the session on Generative AI, ChatGPT, and the Rapidly Changing Role of AI in Healthcare. They discussed the opportunities for these cutting-edge technologies in the short- and long-term while keeping a close eye on potential biases in their development and their impact on equity in care. They also highlighted the role of AMCs (Academic Medical Centers) in preparing for LLM integration, the ins and outs of insurance approvals and appeals, and the regulatory landscape for LLMs in clinical practice, research, and operations. Plus, they reviewed the unique assets for building and validating LLM datasets and approaches to industry collaboration and brainstormed ways to ensure safe and liability-free LLM implementation.
Uber Health Launches Grocery, Over-the-counter Delivery Service for Patients
MedCity News Maria Plescia reports that Uber Health is jumping on the food-as-medicine train. The company is adding grocery and over-the-counter delivery services to its platform, it announced Tuesday. San Francisco-based Uber Health is the healthcare arm of the transportation company Uber. Its solution offers non-emergency medical transportation and prescription delivery. Providers, payers, and case managers can use the same web-based platform they use for these services for grocery and over-the-counter delivery. Other companies that offer healthy food delivery services include FarmboxRx, Instacart, and Kroger. Several payers have also launched food-as-medicine programs, including Kaiser Permanente and Highmark Health.
Why it’s important – There is a growing understanding that supporting healthy food and nutrition can reduce costly healthcare incidents down the road. A recent study found that if payers provided medically-tailored meals to patients who need them, 1.6 million hospitalizations could be avoided annually, and payers could save $13.6 billion. Uber Health will be paid for these services through insurers’ benefit plans. Most (especially Medicaid and Medicare plans) cover transportation and delivery for prescriptions, groceries, and over-the-counter items. Still, some providers, particularly value-based providers, will pay for the benefits out of pocket. Patients won’t have to pay for the service.
Most People With Heart Disease Don’t Use Health Trackers
Christina Frank for Yale University writes in Futurity online that fewer than 1 in 4 people with or at risk for heart disease use wearable health trackers. Only half of those who wear them do so consistently. The population-based, nationally representative study, published in JAMA Network Open, included 9,303 participants from the Health Information National Trends Survey (HINTS). Eighteen percent of people with established CVD and 26% at risk for CVD reported using wearable devices compared with 29% of the general population.
Why it’s important – Older age, lower educational attainment, and lower household income were associated with significantly lower odds of wearable device use, likely due to these populations having less access to these devices or discomfort with using the technology. The people who benefit the most tend to use them the least. Part of it is awareness. People may not recognize the potential value of these devices to the health side, especially since the evidence for their value to health is still evolving. And the other piece is their cost and the fact that people who have health disorders might actually have additional costs to take care of, so these things may seem frivolous to them.
Singapore smart vending machines offer teleconsultations for pharma-only meds
Adan Ang reports that Pharmacy-only medicines can now be accessed via new smart vending machines at Changi General Hospital in his article in Healthcare IT News. Developed by pharmacists, the Pharmacy Smart Interface System (PharmaSis) was authorized by the Health Sciences Authority in April to dispense pharmacy-only medicines with guidance from a CGH pharmacist via teleconsultation. A user first seeks a teleconsultation with a CGH pharmacist, who will assess them before recommending appropriate health advice and medications. They will be guided on selecting medicines, which include those for common minor ailments such as cough, colds, diarrhea, constipation, and fever. PharmaSis also dispenses a range of OTC medicines, as well as hearing aid batteries and other audiology products.
Why it’s important – There is increased interest in developing these types of solutions globally. Two years ago, a similar vending concept was introduced by Fullerton Health, powered by US-based SmartRx’s proprietary drug dispensing hardware and software, to increase access to healthcare for thousands of migrant workers in Singapore amid the pandemic-induced lockdown. In Malaysia, health tech startup Qmed Asia also supports employees’ health by developing and launching the Qmed GO workplace telehealth kiosk. It features medical IoT devices that can measure up to 16 vital parameters, which are then transmitted to and accessed via a patient app and employer dashboard. Docty in India has also developed its own telehealth kiosks, which are being set up across rural and urban poor communities in the country to improve healthcare access.
Here’s what concerns me about the photo of the implementation above. Based on the image, how is patient privacy ensured? If someone stands behind the user, they can hear the whole conversation between the patient and the pharmacist.
A cyberattack is partly to blame for St. Margaret’s Health closing all operations
Two rural Catholic hospitals in Illinois are closing all operations as of Friday, June 16, due in part to a 2021 cyberattack. Healthcare Finance Executive Editor Susan Morse reports that St. Margaret’s Health in Peru and Spring Valley will be closing all current operations as of Friday, June 16, according to a notice on the St. Margaret’s Health website. A ransomware attack in 2021 hit SMP Health, which includes the hospitals of St. Margaret’s Health. The attack halted the hospital’s ability to submit claims to insurers, Medicare or Medicaid for months, sending it into a financial spiral.
Why it’s important – Last year, a report from the American Hospital Association highlighted the variety of causes that resulted in 136 rural hospital closures from 2010 to 2021 and a record 19 closures in 2020 alone. Cyberattacks both threaten patient safety and are costly to hospitals. The most expensive healthcare cyberattack cost an average of $4.4 million in the past 12 months, according to a Ponemon Institute study, including $1.1 million of productivity loss.
Cala Health Launches Wearable Device to Treat Hand Tremors
Katie Adams from MedCity News reports that Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease. The kIQ system is an on-demand, at-home therapy used to manage action hand tremors — those which occur when the patient’s hand is undergoing a voluntary movement, such as typing, picking up a glass of water, or writing a note.
The wrist-worn device senses each patient’s unique tremor signature and individualizes stimulation. It then delivers transcutaneous afferent patterned stimulation (TAPS) therapy, which means it applies specific electrical stimulation patterns through the skin to modulate neural activity and promote therapeutic effects. Using TAPS, the device noninvasively counteracts the patient’s tremor through the nerves on the wrist. After the patient completes an at-home therapy session, they can view their body’s responses via the MyCala.com patient portal.
Why it’s important – More than 7 million Americans struggle with essential tremor (ET), but only one in 10 ET patients is satisfied with their current treatment. The klQ system is prescribed by movement disorder specialists and neurologists for patients with ET or Parkinson’s. Researchers say more studies are needed to determine whether wearable devices can create long-lasting tremor relief from a single session — beyond reducing tremors for an hour or two at a time. They also suggest that further research is needed to solidify wearables as a standalone treatment for essential tremor patients.
“I always have enjoyed people to read for me or to have the chance to listen to how they narrate a book.”
Even for people who love books, finding the opportunity to read can be challenging. Many, then, rely on audiobooks, a convenient alternative to old-fashioned reading. You can listen to the latest bestseller while commuting or cleaning up the house. We can debate whether listening to an audiobook constitutes “reading,” but there’s no doubt that audiobooks have continued to grow in popularity over the last few years.
Since I purchase all of my digital and audiobooks on Amazon, I like the ability to seamlessly jump back and forth between the printed page (to take notes or highlight a section to read again) and the audio version without having to search to find where I left off. I can even use my Alexa device to continue listening to audiobooks in my home office.
So, here are some of my favorite audiobooks from 2023 so far. Note that most are not healthcare related, and many aren’t focused on technology. They just hit my major criteria for selecting an audiobook, and they give me hours of enjoyment. (All hyperlinks are to the audiobook versions on Amazon.)
Look for Me There: Grieving My Father, Finding Myself by Luke Russert. “Look for me there,” news legend Tim Russert would tell his son, Luke, when confirming a pickup spot at an airport, sporting event, or rock concert. After Tim died unexpectedly, Luke kept looking for his father, following in Tim’s footsteps and carving out a highly successful career at NBC News. After eight years covering politics on television, Luke realized he had no good answer as to why he was chasing his father’s legacy. As the son of two accomplished parents—his mother is journalist Maureen Orth of Vanity Fair—Luke felt the pressure of high expectations but suddenly decided to leave the familiar path behind. Tim Russert was one of my favorite news anchors. So, anyone uncertain about the direction of their life or unsure of how to move forward after a loss, Look for Me There is a poignant reflection that offers encouragement to examine our choices, take risks, and discover our truest selves.
Empress of the Nile: The Daredevil Archaeologist Who Saved Egypt’s Ancient Temples from Destruction by Lynne Olsen. I’ve been passionate about ancient Egypt and archaeology since I was young. Growing up in Chicago, a visit to The Oriental Institute was always a highlight of the Summer. And when I finally made it to Egypt in 2019, and visited many of the ancient sites I was fulfilling a longstanding dream. This is the remarkable story of the intrepid French archaeologist who led the international effort to save ancient Egyptian temples from the floodwaters of the Aswan Dam. A willful real-life version of Indiana Jones, Desroches-Noblecourt refused to be cowed by anyone or anything. During World War II she joined the French Resistance and was held by the Nazis; in her fight to save the temples she challenged two of the postwar world’s most daunting leaders, Egypt’s President Nasser and France’s President de Gaulle.
Childhood’s End by Arthur C Clarke. I decided to revisit this novel primarily because of the narrator, who I’ve enjoyed in other audiobooks. The second reason was because it includes an exclusive introduction by Hugo Award-winning author Robert J. Sawyer, who explains why this novel, written in the 1950s, is still relevant today.
Fall in Love with the Problem, Not the Solution: A Handbook for Entrepreneurs by Uri Levine. Unicorns—companies that reach a valuation of more than $1 billion—are rare. Uri Levine has built two. Levine offers an inside look at the creation and sale of Waze and his second unicorn, Moovit, revealing the formula that drove those companies to compete with industry veterans and giants alike. He offers tips on: firing and hiring; disrupting “broken” markets; raising funding; understanding your users; reaching product market fit; making scale-up decisions; going global; and deciding when to sell.
Tech Trends in Practice: The 25 Technologies That Are Driving the 4th Industrial Revolution by Bernard Marr. How will the latest technologies transform your business? The book presents 25 real-world technology trends along with their potential contributions to organizational success. You’ll learn how to integrate existing advancements and plan for those that are on the way. I chose this specifically because there were several technologies that will directly impact healthcare and I wanted a broader opinion on their potential benefits.
Life 3.0: Being Human in the Age of Artificial Intelligence by Max Tegmark. The rise of AI has the potential to transform our future more than any other technology – and there’s nobody better qualified or situated to explore that future than Max Tegmark, an MIT professor who’s helped mainstream research on how to keep AI beneficial. This book empowers you to join what may be the most important conversation of our time. It doesn’t shy away from the full range of viewpoints or from the most controversial issues – from superintelligence to meaning, consciousness, and the ultimate physical limits on life in the cosmos.
In the Blood: How Two Outsiders Solved a Centuries-Old Medical Mystery and Took On the US Army by Charles Barber. At the 1993 Battle of Mogadishu, dramatized by the popular film Black Hawk Down, the majority of soldiers who died were killed instantly or bled to death before they could reach an operating table. This tragedy reinforced the need for a revolutionary treatment that could transform trauma medicine. So, when Frank Hursey and Bart Gullong—who had no medical or military experience—discovered that a cheap, crushed rock called zeolite had blood‑clotting properties, they brought it to the military’s attention. The Marines and the Navy adopted the resulting product, QuikClot, immediately. The Army, however, resisted. It had two products of its own being developed to prevent excessive bleeds, one of which had already cost tens of millions of dollars. The other, “Factor Seven,” had a more dangerous complication: its side effects could be deadly. Unwilling to let its efforts end in failure—and led by the highly influential surgeon Colonel John Holcomb—the Army set out to smear QuikClot’s reputation. In the Blood recounts this little‑known David‑and‑Goliath story of corruption, greed, and power within the military—and the devastating consequences of unchecked institutional arrogance.
The People’s Hospital: Hope and Peril in American Medicine by Ricardo Nuila, MD. Where does one go without health insurance, when turned away by hospitals, clinics, and doctors? In The People’s Hospital, we follow the lives of five uninsured Houstonians as their struggle for survival leads them to a hospital where insurance comes second to genuine care. Each patient eventually lands at Ben Taub, the county hospital where Dr. Nuila has worked for over a decade. Nuila delves with empathy into the experiences of his patients, braiding their dramas into a singular narrative that contradicts the established idea that the only way to receive good healthcare is with good insurance.
What happened in health care technology this week, and why it’s important.
AI-powered scribe tool enables more patients, less burnout
A major issue with primary care, especially value-based care, is how much documentation burden there is for providers: It means hours of “pajama time” with the electronic health record after dinner and hours of more charting at home on weekends. Bill Siwicki of Healthcare IT News interviews Dr. Kendell Cannon, who describes how her primary care practice sifted through the hype of artificial intelligence and found a scribe that does what it promises.
Why it’s important – “This space has been full of marketing hype for a very long time, with companies claiming they have technology that works or promising that it will be here soon,” Cannon advised. “When evaluating AI technologies, I would recommend you try it for yourself before you believe anything. If a vendor cannot do live, unscripted demos, they’re not ready for production. “You should be able to bring your team to pressure test it across a range of realistic scenarios before deciding to invest any resources,” she concluded. “I’ve seen too many examples of AI companies making promises and wasting a lot of our time and resources because they never ended up delivering on those promises.”
Infographic of the week – This was a tough week in many areas of the country because of smoke from the wildfires in Canada. The Environmental Protection Agency released the graphic below to help people understand the health effects of air pollution.
Google strikes deal with Mayo Clinic to comb patient records using generative AI
Casey Ross of Stat Health Tech reports that Google will embed its generative AI technology into computer systems at Mayo Clinic and other health systems to make it easier to search vast repositories of patient data and automate administrative tasks, the organizations said Wednesday. The technology is designed to function like a super-charged Google search for health records, allowing hospitals to find and link information about patients to improve care and research. Google said it had configured its generative AI tools, which can be used to create conversational chatbots, to comply with the federal privacy law known as HIPAA.
Why it’s important – The rapid-fire effort to deploy the technology comes amid increasing competition with Microsoft and other large companies vying for business from healthcare companies eager to use a more powerful form of AI. It remains to be seen whether the technology will produce enough benefits to justify its costs. While generative AI systems have improved and shown the potential to understand medical information and generate useful replies, large models trained on web-scale data also have significant drawbacks. They are expensive to run and consume massive amounts of energy. They also hallucinate and provide inaccurate information.
Podcast of the week – Abraham Verghese is an American physician and Professor of the Theory and Practice of Medicine and Vice Chair of Education at Stanford University Medical School. He is also the author of four best-selling books, two memoirs, and two novels. In his first Fixing Healthcare interview, Verghese talks about his newest work of fiction, “The Covenant of Water,” which sits at No. 4 on the New York Times list and is an Oprah book-club selection. The discussion takes listeners on a journey into the mind of an exceptional physician and writer. Verghese compares his approach to writing vs. medicine and concludes, “the gaze is the same.” And because he sees the world similarly, whether he’s sitting in front of a keyboard or a sick patient, he shares a fascinating perspective on physician leadership, end-of-life care, and myriad issues that transcend healthcare. You can listen here.
Programmable 3D printed wound dressing could improve treatment for burn, cancer patients
Researchers from The University of Waterloo have developed intelligent hydrogel materials for use as a reusable wound dressing. In developing the dressing, the researchers conducted a 3D scan of the patient’s face and body parts to customize it to an individual’s needs. This enables the dressing to make good contact with surfaces like noses and fingers, making it ideal for creating personalized wound dressings for burn patients.
Why it’s important – One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. This new dressing could enhance the healing process for burn patients and have potential applications for drug delivery in cancer treatment and the cosmetic industry. The material also has applications for cancer treatment. In traditional chemotherapy treatment, a patient may need to be in a clinic for hours, which can be tiring and uncomfortable. This dressing can provide a constant drug release outside the clinic setting, alleviating some of the challenges associated with traditional methods.
Novocure’s electric fields device prolongs survival in lung cancer, but doubts remain
Stat’s Adam Feuerstein reports that a medical device made by Novocure that creates electric fields in the lungs via wearable skin patches extended the survival of patients with lung cancer in a clinical trial. Novocure’s study achieved its primary goal and showed a survival benefit for patients with lung cancer that progressed following initial chemotherapy. But those data don’t fit the current medical practice for patients with lung cancer because nearly 70% of study participants didn’t receive initial treatment with an immune checkpoint inhibitor such as Merck’s Keytruda, which has come to dominate current therapy.
The Optune device, also called tumor treating fields, consists of four wired patches applied with skin adhesive to the upper body surrounding the lungs. When connected to an external, battery-powered generator, the patches create an electrical field tuned to interfere with the cell division of tumor cells while sparing healthy cells. Patients are instructed to wear the device for up to 18 hours daily.
Why it’s important – The findings could lead to a new approval for the Optune device beyond its current marketing clearance to treat a type of brain cancer. Delivering additional sales, however, could be a significant challenge. The device did not delay tumor progression or shrink tumors better than standard therapy. The most commonly reported side effect was minor skin irritation caused by the patch adhesive.
Avatar Medical wins FDA clearance for VR surgical planning tech
Avatar Medical announced on June 6th that its virtual reality (VR) surgical planning technology received FDA 510(k) clearance. Sean Whooley reports on the development in his article in Mass Device online. The company designed its proprietary technology based on four years of research in human-data interaction and machine learning. Avatar Medical conducted this research at the Institut Pasteur and Institut Curie. Use of the platform in the U.S. to date spans more than 100 surgeons across 20 different hospitals and universities. The system’s uses include case studies, student education, and patient engagement, Avatar Medical said.
Why it’s important – Patient “avatars” generate instantly from CT scans or MRI for use with the VR platform. It features underlying technology developed by the company, which has a U.S. subsidiary in Mountain View, California. The company said its platform serves as a valuable tool for pre-operative planning. It can also be displayed during surgical procedures.
FDA’s letter to medical device maker iRhythm is a warning for the industry
Stat’s Lizzy Lawrence reports that heart monitoring company iRhythm is in hot water with the Food and Drug Administration, which issued a stern warning letter to the device maker this week for marketing its product for “high-risk” patients and changing its algorithm without seeking the FDA’s permission. iRhythm sells a wearable monitor called the Zio AT system that detects irregular heartbeats for up to two weeks. Its monitors do not present this data in real time, so they are not intended for patients in critical care. But according to the FDA, iRhythm told customers that its devices provided “near real-time monitoring” and could be used for “high-risk patients.”
The FDA first raised its concerns after an agency investigation in August 2022. The company responded to the FDA’s various concerns with seven separate letters. The FDA wasn’t satisfied and instead issued the warning letter. The FDA also slammed the company for not adequately informing doctors and patients about its device’s transmission limit. iRhythm’s monitor can automatically detect up to 500 arrhythmias. After that, the device must be replaced. The FDA said iRhythm did not make this limitation clear — with serious consequences.
Why it’s important – The letter highlights the FDA’s growing scrutiny of digital health and patient monitoring tools — as well as the grave impacts even small device glitches can have on patients. The FDA routinely issues warning letters to enforce patient safety, but regulators holding a digital health company accountable for making unapproved claims and changes remains rare. The FDA has only recently begun seriously regulating digital health technology, particularly in the artificial intelligence space. Multiple investigations by STAT have found that software tools can deliver inaccurate results that advise doctors poorly, send false alarms, and add bias to health care.
Another huge US medical data breach confirmed after Fortra mass-hack
Hackers stole another half a million people’s personal and health information during a ransomware attack on a technology vendor earlier this year. Zach Whittaker from Tech Crunch reports that Intellihartx, a Tennessee-based company that handles patient payment balances and collections, said in a notice filed with the Maine attorney general’s office that 489,830 patients had information stolen in the cyberattack targeting its vendor, Fortra. According to the notice, the hackers stole patient names, addresses, dates of birth, and Social Security numbers. The breach also compromised patient medical billing and insurance information, as well as diagnoses and medication.
Why it’s important – Millions of patients across the United States also had their health information stolen in the cyberattack, including children’s data. The impact of Clop’s ransomware attack prompted the U.S. Department of Health and Human Services to publish an alert warning that the ransomware group was targeting the healthcare industry.